Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016, vol. 28. 2017.
World Health Organization. HIV Drug Resistance Report 2017. Licence: CC BY-NC-SA 3.0 IGO.
Cihlar T, Fordyce M. Current status and prospects of HIV treatment. Curr Opin Virol. 2016;18:50–6.
Article
CAS
PubMed
Google Scholar
Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012;2(4):a007161.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1):69–81.
Article
CAS
PubMed
Google Scholar
Lindl KA, et al. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol. 2010;5(3):294–309.
Article
PubMed
PubMed Central
Google Scholar
Heaton RK, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.
Article
CAS
PubMed
Google Scholar
Mateen FJ, et al. Neurologic disorders incidence in HIV+ vs HIV− men: Multicenter AIDS Cohort Study, 1996–2011. Neurology. 2012;79(18):1873–80.
Article
PubMed
PubMed Central
Google Scholar
Alford K, Vera JH. Cognitive impairment in people living with HIV in the ART era: a review. Brit Med Bull. 2018;127:55–68.
Article
CAS
PubMed
Google Scholar
Carvalhal A, et al. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neurovirol. 2016;22(3):349–57.
Article
CAS
PubMed
Google Scholar
Caniglia EC, et al. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology. 2014;83(2):134–41.
Article
PubMed
PubMed Central
Google Scholar
Nightingale S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79.
Article
CAS
PubMed
Google Scholar
Huotari J, Helenius A. Endosome maturation. EMBO J. 2011;30(17):3481–500.
Article
CAS
PubMed
PubMed Central
Google Scholar
Edgar JR. Q&A: What are exosomes, exactly? BMC Biol. 2016;14:46.
Article
PubMed
PubMed Central
CAS
Google Scholar
Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnstone RM. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol. 1992;70(3–4):179–90.
Article
CAS
PubMed
Google Scholar
Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol. 2013;200(4):367–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rashed MH, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017;18(3):538.
Article
CAS
Google Scholar
Hurley JH. ESCRTs are everywhere. EMBO J. 2015;34(19):2398–407.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hurley JH. The ESCRT complexes. Crit Rev Biochem Mol Biol. 2010;45(6):463–87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Villarroya-Beltri C, et al. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 2014;28:3–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Armstrong D, Wildman DE. Extracellular vesicles and the promise of continuous liquid biopsies. J Pathol Transl Med. 2018;52(1):1–8.
Article
PubMed
PubMed Central
Google Scholar
McKelvey KJ, et al. Exosomes: mechanisms of uptake. J Circ Biomark. 2015;4:7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shi Y, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14:493–507.
Article
CAS
PubMed
Google Scholar
Fevrier B, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A. 2004;101(26):9683–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Asai H, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
de Jong OG, et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles. 2012. https://doi.org/10.3402/jev.v1i0.18396.
Article
PubMed
PubMed Central
Google Scholar
Momen-Heravi F, et al. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med. 2015;13:261.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kreimer S, et al. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics. J Proteome Res. 2015;14(6):2367–84.
Article
CAS
PubMed
Google Scholar
Masaoutis C, et al. Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice. Biochimie. 2018;151:27–36.
Article
CAS
PubMed
Google Scholar
Ensoli B, et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature. 1990;345(6270):84–6.
Article
CAS
PubMed
Google Scholar
Levy DN, et al. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1994;91(23):10873–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fujii Y, et al. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett. 1996;393(1):93–6.
Article
CAS
PubMed
Google Scholar
Hoshino S, et al. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers. AIDS Res Hum Retrovir. 2007;23(3):391–7.
Article
CAS
PubMed
Google Scholar
Mediouni S, et al. Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. Infect Disord Drug Targets. 2012;12(1):81–6.
Article
CAS
PubMed
Google Scholar
Lenassi M, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2010;11(1):110–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Puzar Dominkus P, et al. Nef is secreted in exosomes from Nef.GFP-expressing and HIV-1-infected human astrocytes. J Neurovirol. 2017;23(5):713–24.
Article
CAS
PubMed
Google Scholar
McNamara RP, et al. Nef secretion into extracellular vesicles or exosomes is conserved across human and simian immunodeficiency viruses. MBio. 2018;9(1):e02344.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rahimian P, He JJ. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein. J Neurovirol. 2016;22(6):774–88.
Article
CAS
PubMed
PubMed Central
Google Scholar
Park IW, He JJ. HIV-1 is budded from CD4+ T lymphocytes independently of exosomes. Virol J. 2010;7:234.
Article
PubMed
PubMed Central
CAS
Google Scholar
Arakelyan A, et al. Extracellular vesicles carry HIV Env and facilitate HIV infection of human lymphoid tissue. Sci Rep. 2017;7(1):1695.
Article
PubMed
PubMed Central
CAS
Google Scholar
Anyanwu SI, et al. Detection of HIV-1 and human proteins in urinary extracellular vesicles from HIV+ patients. Adv Virol. 2018;2018:7863412.
Article
PubMed
PubMed Central
Google Scholar
Narayanan A, et al. Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem. 2013;288(27):20014–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klase Z, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology. 2009;6:18.
Article
PubMed
PubMed Central
CAS
Google Scholar
Narayanan A, et al. Analysis of the roles of HIV-derived microRNAs. Expert Opin Biol Ther. 2011;11(1):17–29.
Article
CAS
PubMed
Google Scholar
Barclay RA, et al. Exosomes from uninfected cells activate transcription of latent HIV-1. J Biol Chem. 2017;292(28):11682–701.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hladnik A, et al. Trans-activation response element RNA is detectable in the plasma of a subset of Aviremic HIV-1-infected patients. Acta Chim Slov. 2017;64:530–6.
Article
CAS
PubMed
Google Scholar
Jaworski E, et al. The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells. PLoS ONE. 2014;9(5):e96778.
Article
PubMed
PubMed Central
CAS
Google Scholar
Columba Cabezas S, Federico M. Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes. Cell Microbiol. 2013;15(3):412–29.
Article
CAS
PubMed
Google Scholar
Sampey GC, et al. Exosomes and their role in CNS viral infections. J Neurovirol. 2014;20(3):199–208.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anderson MR, Kashanchi F, Jacobson S. Exosomes in viral disease. Neurotherapeutics. 2016;13(3):535–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chahar HS, Bao X, Casola A. Exosomes and their role in the life cycle and pathogenesis of RNA viruses. Viruses. 2015;7(6):3204–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haase AT. Pathogenesis of lentivirus infections. Nature. 1986;322(6075):130–6.
Article
CAS
PubMed
Google Scholar
Gould SJ, Booth AM, Hildreth JE. The Trojan exosome hypothesis. Proc Natl Acad Sci U S A. 2003;100(19):10592–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Booth AM, et al. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006;172(6):923–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nguyen DG, et al. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem. 2003;278(52):52347–54.
Article
CAS
PubMed
Google Scholar
Chertova E, et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol. 2006;80(18):9039–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sherer NM, et al. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic. 2003;4(11):785–801.
Article
CAS
PubMed
Google Scholar
Pelchen-Matthews A, Raposo G, Marsh M. Endosomes, exosomes and Trojan viruses. Trends Microbiol. 2004;12(7):310–6.
Article
CAS
PubMed
Google Scholar
Izquierdo-Useros N, et al. Exosomes and retroviruses: the chicken or the egg? Cell Microbiol. 2011;13(1):10–7.
Article
CAS
PubMed
Google Scholar
Welsch S, et al. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 2007;3(3):e36.
Article
PubMed
PubMed Central
CAS
Google Scholar
Deneka M, et al. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol. 2007;177(2):329–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grigorov B, et al. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology. 2009;6:28.
Article
PubMed
PubMed Central
CAS
Google Scholar
Coren LV, Shatzer T, Ott DE. CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway. Retrovirology. 2008;5:64.
Article
PubMed
PubMed Central
CAS
Google Scholar
Fang Y, et al. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 2007;5(6):e158.
Article
PubMed
PubMed Central
CAS
Google Scholar
Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J Virol. 2007;81(15):7873–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jager S, et al. Global landscape of HIV-human protein complexes. Nature. 2011;481(7381):365–70.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25(6):364–72.
Article
CAS
PubMed
Google Scholar
Florin L, Lang T. Tetraspanin assemblies in virus infection. Front Immunol. 2018;9:1140.
Article
PubMed
PubMed Central
CAS
Google Scholar
Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res. 2009;315(9):1584–92.
Article
CAS
PubMed
Google Scholar
Perez-Hernandez D, et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem. 2013;288(17):11649–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lalonde MS, et al. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. PLoS Pathog. 2011;7(5):e1002038.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A. 2001;98(24):13925–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ono A. Relationships between plasma membrane microdomains and HIV-1 assembly. Biol Cell. 2010;102(6):335–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tan SS, et al. Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles. 2013. https://doi.org/10.3402/jev.v2i0.22614.
Article
PubMed
PubMed Central
Google Scholar
Valapala M, Vishwanatha JK. Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. J Biol Chem. 2011;286(35):30911–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hogue IB, et al. Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. J Virol. 2011;85(19):9749–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sette P, et al. The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J Virol. 2010;84(16):8181–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Usami Y, et al. The ESCRT pathway and HIV-1 budding. Biochem Soc Trans. 2009;37(Pt 1):181–4.
Article
CAS
PubMed
Google Scholar
Chen L, et al. Pathways of production and delivery of hepatocyte exosomes. J Cell Commun Signal. 2018;12(1):343–57.
Article
PubMed
Google Scholar
Mele AR, et al. Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter. Traffic. 2018. https://doi.org/10.1111/tra.12578.
Article
PubMed
PubMed Central
Google Scholar
Sutaria DS, et al. Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery. J Extracell Vesicles. 2017;6(1):1333882.
Article
PubMed
PubMed Central
Google Scholar
Klase Z, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol. 2007;8:63.
Article
PubMed
PubMed Central
CAS
Google Scholar
Melo SA, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014;26(5):707–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janas T, et al. Mechanisms of RNA loading into exosomes. FEBS Lett. 2015;589(13):1391–8.
Article
CAS
PubMed
Google Scholar
Roeth JF, Collins KL. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev. 2006;70(2):548–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Campbell TD, et al. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn Dis. 2008;18(2 Suppl 2):S2-14-9.
PubMed
Google Scholar
Witkowski W, Verhasselt B. Contributions of HIV-1 Nef to immune dysregulation in HIV-infected patients: a therapeutic target? Expert Opin Ther Targets. 2013;17(11):1345–56.
Article
CAS
PubMed
Google Scholar
Giese SI, et al. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology. 2006;355(2):175–91.
Article
CAS
PubMed
Google Scholar
Mukerji J, et al. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology. 2012;9:33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olivetta E, et al. The contribution of extracellular Nef to HIV-induced pathogenesis. Curr Drug Targets. 2016;17(1):46–53.
Article
CAS
PubMed
Google Scholar
Ali SA, et al. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res Hum Retrovir. 2010;26(2):173–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shelton MN, et al. Secretion modification region-derived peptide disrupts HIV-1 Nef’s interaction with mortalin and blocks virus and Nef exosome release. J Virol. 2012;86(1):406–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pilzer D, et al. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol. 2005;27(3):375–87.
Article
CAS
PubMed
Google Scholar
Muratori C, et al. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe. 2009;6(3):218–30.
Article
CAS
PubMed
Google Scholar
Arenaccio C, et al. Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1. Retrovirology. 2014;11:46.
Article
PubMed
PubMed Central
CAS
Google Scholar
Arenaccio C, et al. Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. J Virol. 2014;88(19):11529–39.
Article
PubMed
PubMed Central
CAS
Google Scholar
Arenaccio C, et al. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1. Retrovirology. 2015;12:87.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sampey GC, et al. Exosomes from HIV-1-infected cells stimulate production of pro-inflammatory cytokines through trans-activating response (TAR) RNA. J Biol Chem. 2016;291(3):1251–66.
Article
CAS
PubMed
Google Scholar
Bernard MA, et al. Novel HIV-1 miRNAs stimulate TNFalpha release in human macrophages via TLR8 signaling pathway. PLoS ONE. 2014;9(9):e106006.
Article
PubMed
PubMed Central
CAS
Google Scholar
Stroud JC, et al. Structural basis of HIV-1 activation by NF-kappaB—a higher-order complex of p50:RelA bound to the HIV-1 LTR. J Mol Biol. 2009;393(1):98–112.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest. 2001;107(2):143–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Raymond AD, et al. HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviru. 2011;27(2):167–78.
Article
CAS
Google Scholar
Konadu KA, et al. Hallmarks of HIV-1 pathogenesis are modulated by Nef’s secretion modification region. J AIDS Clin Res. 2015. https://doi.org/10.4172/2155-6113.1000476.
Article
PubMed
PubMed Central
Google Scholar
Markle TJ, Philip M, Brockman MA. HIV-1 Nef and T-cell activation: a history of contradictions. Future Virol. 2013. https://doi.org/10.2217/fvl.13.20.
Article
PubMed
PubMed Central
Google Scholar
Raymond AD, et al. Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides. J Neurovirol. 2016;22(2):129–39.
Article
CAS
PubMed
Google Scholar
Felli C, et al. HIV-1 Nef signaling in intestinal mucosa epithelium suggests the existence of an active inter-kingdom crosstalk mediated by exosomes. Front Microbiol. 2017;8:1022.
Article
PubMed
PubMed Central
Google Scholar
Atluri VS, et al. Effect of human immunodeficiency virus on blood–brain barrier integrity and function: an update. Front Cell Neurosci. 2015;9:212.
Article
PubMed
PubMed Central
CAS
Google Scholar
Corasaniti MT, et al. Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem Biophys Res Commun. 2000;274(3):664–9.
Article
CAS
PubMed
Google Scholar
Alirezaei M, et al. Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. J Neurosci. 2007;27(41):11047–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Capone C, et al. A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity. Free Radic Biol Med. 2013;63:99–107.
Article
CAS
PubMed
Google Scholar
Ferrucci A, Nonnemacher MR, Wigdahl B. Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis. Adv Virus Res. 2011;81:165–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Malik S, Eugenin EA. Mechanisms of HIV Neuropathogenesis: role of Cellular Communication Systems. Curr HIV Res. 2016;14(5):400–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
James T, et al. Defining the roles for Vpr in HIV-1-associated neuropathogenesis. J Neurovirol. 2016;22(4):403–15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh IN, et al. Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons. Neuroscience. 2005;135(3):781–90.
Article
CAS
PubMed
Google Scholar
Khan MB, et al. Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Abeta(1-42) secretion in SH-SY5Y neural cells. J Neurovirol. 2016;22(2):179–90.
Article
CAS
PubMed
Google Scholar
Ortega M, Ances BM. Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol. 2014;9(4):483–91.
Article
PubMed
PubMed Central
Google Scholar
Andras IE, et al. Extracellular vesicles of the blood–brain barrier: role in the HIV-1 associated amyloid beta pathology. Mol Cell Neurosci. 2017;79:12–22.
Article
CAS
PubMed
Google Scholar
Lee JH, et al. HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases. Mol Cell. 2013;49(4):668–79.
Article
CAS
PubMed
Google Scholar
Kosaka N, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285(23):17442–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dinkins MB, et al. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(8):1792–800.
Article
CAS
PubMed
PubMed Central
Google Scholar
Essandoh K, et al. Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction. Biochim Biophys Acta. 2015;1852(11):2362–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fleshner M, Crane CR. Exosomes, DAMPs and miRNA: features of stress physiology and immune homeostasis. Trends Immunol. 2017;38(10):768–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang MB, et al. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells. Oncotarget. 2017;8(7):11302–15.
PubMed
PubMed Central
Google Scholar
Levy S. Function of the tetraspanin molecule CD81 in B and T cells. Immunol Res. 2014;58(2–3):179–85.
Article
CAS
PubMed
Google Scholar
Ji C, et al. Prevention of hepatitis C virus infection and spread in human liver chimeric mice by an anti-CD81 monoclonal antibody. Hepatology. 2015;61(4):1136–44.
Article
CAS
PubMed
Google Scholar
Liu X, et al. Synthesized peptide 710-725 from HCV subtype 1a E2 glycoprotein blocks HCV infection through competitive binding of CD81. Int J Mol Med. 2016;37(3):836–42.
Article
CAS
PubMed
Google Scholar
Cui HK, et al. Stapled peptide-based membrane fusion inhibitors of hepatitis C virus. Bioorg Med Chem. 2013;21(12):3547–54.
Article
CAS
PubMed
Google Scholar
Scarborough RJ, Gatignol A. RNA interference therapies for an HIV-1 functional cure. Viruses. 2017. https://doi.org/10.3390/v10010008.
Article
PubMed
PubMed Central
Google Scholar
Bobbin ML, Burnett JC, Rossi JJ. RNA interference approaches for treatment of HIV-1 infection. Genome Med. 2015;7(1):50.
Article
PubMed
PubMed Central
CAS
Google Scholar
Leonard JN, et al. HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe. 2008;4(5):484–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mousseau G, Valente S. Strategies to block HIV transcription: focus on small molecule tat inhibitors. Biology (Basel). 2012;1(3):668–97.
CAS
PubMed Central
Google Scholar
Bohjanen PR, Liu Y, Garcia-Blanco MA. TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation. Nucleic Acids Res. 1997;25(22):4481–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mousseau G, et al. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. Cell Host Microbe. 2012;12(1):97–108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hayashi T, et al. Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription. Antivir Res. 2017;146:76–85.
Article
CAS
PubMed
Google Scholar
Kessing CF, et al. In vivo suppression of HIV rebound by didehydro-cortistatin A, a “block-and-lock” strategy for HIV-1 treatment. Cell Rep. 2017;21(3):600–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blazek D, et al. The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells. J Gen Virol. 2016;97(1):220–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tumne A, et al. Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells. J Virol. 2009;83(9):4354–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
Madison MN, Okeoma CM. Exosomes: implications in HIV-1 pathogenesis. Viruses. 2015;7(7):4093–118.
Article
CAS
PubMed
PubMed Central
Google Scholar
Madison MN, Roller RJ, Okeoma CM. Human semen contains exosomes with potent anti-HIV-1 activity. Retrovirology. 2014;11:102.
Article
PubMed
PubMed Central
Google Scholar
Welch JL, et al. Semen exosomes promote transcriptional silencing of HIV-1 by disrupting NF-kB/Sp1/Tat circuitry. J Virol. 2018. https://doi.org/10.1128/JVI.00731-18.
Article
PubMed
PubMed Central
Google Scholar
Medapalli RK, He JC, Klotman PE. HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens. 2011;20(3):306–11.
Article
PubMed
PubMed Central
Google Scholar
Kim Y, Anderson JL, Lewin SR. Getting the “kill” into “shock and kill”: strategies to eliminate latent HIV. Cell Host Microbe. 2018;23(1):14–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Darcis G, Das AT, Berkhout B. Tackling HIV persistence: pharmacological versus CRISPR-based shock strategies. Viruses. 2018. https://doi.org/10.3390/v10040157.
Article
PubMed
PubMed Central
Google Scholar
Kadiu I, et al. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J Immunol. 2012;189(2):744–54.
Article
CAS
PubMed
Google Scholar